Form 4: Glaukos Director Exercises Options, Sells Shares
Insider Transaction Report
Glaukos Corp. Director Marc Stapley executed a series of transactions, including exercising stock options and selling common stock, under a pre-arranged 10b5-1 trading plan.
Summary
- Marc Stapley, a Director of Glaukos Corp. (GKOS), acquired 15,000 shares of common stock by exercising stock options at a price of $24.69 per share.
- Following the option exercise, Mr. Stapley disposed of a total of 14,000 shares of common stock through multiple sales transactions.
- The sales occurred at weighted average prices ranging from $126.07 to $129.78 per share.
- All reported transactions, including both the option exercise and subsequent sales, were conducted pursuant to a Rule 10b5-1 trading plan adopted on June 4, 2025.
- After these transactions, Mr. Stapley beneficially owns 37,449 shares of Glaukos Corp. common stock, which includes 2,835 restricted stock units that have not yet vested or been delivered.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions under a pre-arranged 10b5-1 plan. While the director sold shares, the exercise of options at a much lower price is a positive for the insider, and the plan mitigates any negative signaling from the sales, resulting in a neutral overall sentiment for the company.
Positives
- The exercise of stock options at a strike price of $24.69, significantly below the sale prices, indicates a profitable transaction for the insider.
- The use of a Rule 10b5-1 trading plan demonstrates pre-planning and adherence to insider trading regulations, reducing the perception of opportunistic trading.
Negatives
- The sale of shares by a director, even under a pre-arranged plan, could be interpreted by some investors as a signal of reduced confidence, although this is often mitigated by the 10b5-1 plan's nature.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. This plan allows insiders to set up a pre-scheduled plan to buy or sell company stock to avoid accusations of insider trading. | 06/04/2025 | Enhances transparency and compliance with insider trading rules by pre-arranging transactions, reducing the perception of opportunistic trading. |
Stakeholder Impact
- Shareholders: The sale of shares by a director could slightly increase the public float. While the transactions are pre-planned, some investors may still monitor insider selling as a potential signal, though the impact is generally limited for routine 10b5-1 sales.
Key Dates
| Date | Description |
|---|---|
| 06/02/2017 | Date stock option became exercisable. |
| 06/04/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 01/22/2026 | Date of earliest transaction (stock option exercise and subsequent sales). |
| 01/26/2026 | Signature date of the reporting person's attorney-in-fact. |
| 06/02/2026 | Expiration date of the stock option. |
Keywords
Glaukos Corp, GKOS, Marc Stapley, Insider Trading, Form 4, Stock Options, Share Sale, 10b5-1 Plan, Director Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.